ASPM, CDCA7, CENPF and EPHB2 were upregulated in Non-pan-NET G3 while CDHR3, FTCD, PTPRN and SERPINA1 in Non-pan-NEC (Supplementary Fig. S2B). Here, CDCA7 is linked to neuroendocrine carcinoma.